A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- New Technology Promises to Revolutionize Valvular Heart Disease Care.
- DNA test says it can predict opioid addiction risk. Skeptics aren’t so sure.
- Transfer Scholars Initiative prepares N.J. community college students to thrive at selective four-year schools.
- Scientists May Have Discovered Reason for Long COVID Brain Fog—Here’s Why It Matters.
- Are You at Risk for Addiction?